CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients
暂无分享,去创建一个
S. Rauser | A. Walch | B. Balluff | S. Bielack | D. Baumhoer | M. Nathrath | G. Jundt | J. Smida | Stephanie Zillmer | Mareike Elsner | Cédrik Schoene
[1] S. Rauser,et al. MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. , 2011, The American journal of pathology.
[2] M. Rosemann,et al. Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma , 2010, Clinical Cancer Research.
[3] J. Ramser,et al. Identification of brain- and bone-specific breast cancer metastasis genes. , 2009, Cancer letters.
[4] G. Kristiansen,et al. Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater , 2009, Modern Pathology.
[5] Q Wang,et al. Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer , 2007, Oncogene.
[6] R. Steele,et al. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer , 2006, Journal of Clinical Pathology.
[7] Stefan Roepcke,et al. Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III , 2006, International journal of cancer.
[8] Yi Zhang,et al. Genes associated with breast cancer metastatic to bone. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Erming Tian,et al. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. , 2005, Virology.
[10] A. Stromberg,et al. Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells. , 2004, Molecular cancer research : MCR.
[11] Allison Jones,et al. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells , 2003, Oncogene.
[12] R. Salunga,et al. Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] David Yang,et al. Identification of cervical cancer markers by cDNA and tissue microarrays. , 2003, Cancer research.
[14] L. Lanningham-Foster,et al. Overexpression of CRIP in transgenic mice alters cytokine patterns and the immune response. , 2002, American journal of physiology. Endocrinology and metabolism.
[15] Tatjana Crnogorac-Jurcevic,et al. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. , 2002, The American journal of pathology.
[16] L. Lanningham-Foster,et al. Regulation of cysteine-rich intestinal protein, a zinc finger protein, by mediators of the immune response. , 2000, The Journal of infectious diseases.
[17] J. Gordon,et al. Developmental regulation of a gene that encodes a cysteine-rich intestinal protein and maps near the murine immunoglobulin heavy chain locus. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[18] P. Komminoth,et al. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2013 .
[19] Colin Kong,et al. Biomarkers in Osteosarcoma. , 2009, Expert opinion on medical diagnostics.
[20] G. Delling,et al. Morphological grades of regression in osteosarcoma after polychemotherapy — Study COSS 80 , 2004, Journal of Cancer Research and Clinical Oncology.
[21] W. Winkelmann,et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] F. Mertens,et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .